GX-19N

· Genexine, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GX-19N, covering 2022-04-12 to 2025-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults [Phase 1, Phase 2]